Latest Transformation News

Coles Group delivered a robust FY25 performance with a 3.6% rise in group sales revenue and a strong 10.7% increase in underlying EBITDA, driven by its supermarkets division and digital expansion.

SPC Global Holdings Ltd reported a 40.66% surge in gross revenue to $383 million for FY2025, driven by strategic acquisitions and operational growth. However, the group recorded a net loss of $41.1 million, reflecting restructuring and merger costs.

Viva Energy's half-year results reveal a resilient Commercial segment offsetting pressures in Refining and Retail, as the company advances its retail transformation and cost synergy targets.

Coles Group Limited reported modest growth in FY25 with $44.35 billion revenue and $1.08 billion net profit, underpinned by major supply chain investments and sustainability milestones. The company maintained dividends but faces ongoing legal challenges.

IVE Group Limited reported a 69% jump in net profit for FY25 despite a slight revenue dip, driven by margin expansion and operational efficiencies. The company maintains a strong balance sheet and outlines ambitious growth and sustainability plans for FY26.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Australian Clinical Labs reported a 6.4% revenue increase and an 8.7% rise in underlying EBIT for FY25, maintaining disciplined growth and operational efficiency in a complex healthcare environment.

Holista Colltech has inked a binding supply and development agreement with US-based Regenerex Pharma to exclusively supply proprietary ovine collagen for advanced wound care products, targeting the lucrative US market initially with plans for global expansion.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its plant-based milks and dairy segments. The company has resolved legacy litigation issues and is now focused on navigating the $610 million convertible note maturity due in 2027.

Noumi Limited reported modest revenue growth and a significant rise in adjusted EBITDA for FY25, driven by its Milklab brand’s strong performance and a continued turnaround in its Dairy & Nutritionals segment. The company also resolved all legacy legal issues, positioning itself for future growth.

Askari Metals is gearing up for a pivotal shareholder meeting to approve its Ethiopian gold and copper acquisition, while restructuring debt and expanding European investor outreach.

Firebrick Pharma has secured an exclusive licensing agreement with Innorini Pte Ltd to distribute Nasodine products across Singapore, Malaysia, Brunei, and Mauritius, aiming to reduce marketing expenses and broaden market access.